## **Trustees’ annual report for the period** 

## **From:  01/04/23 Period start date** 

## **To: Period end date 01/04/24** 

## **Charity name: Crescent Kids** 

## **Charity registration number: 1173388** 

## **Objectives and activities** 

|**Objectives and activities**|**Objectives and activities**|**Objectives and activities**|
|---|---|---|
|SORP reference|||
|Summary of the purposes of<br>the charity as set out in its<br>governing document<br>Para 1.17<br>1. Providing support, advice, education and<br>information about sickle<br>cell and thalassaemia.<br>2. Providing information and raising awareness to<br>gradually<br>decrease the number of children born with sickle<br>cell and<br>thalassaemia<br>3. Providing grants and funds towards studies to<br>advance health and<br>find a cure for Sickle Cell and thalassaemia.|||
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or services<br>identified in the accounts.|Para 1.17 and<br>1.19|Between April 2023 and April 2024, Crescent<br>Kids focused on delivering accessible, engaging<br>education and awareness for families affected by<br>sickle cell disease. We provided online education<br>sessions covering key topics such as navigating<br>school with a chronic illness, understanding<br>medical procedures, and promoting emotional<br>well-being. These sessions empowered parents<br>and carers with practical knowledge and helped<br>children feel seen and supported.<br>We also expanded our digital reach by launching<br>our YouTube channel and growing our presence<br>on Instagram and LinkedIn, sharing short,<br>informative videos featuring the voices and<br>experiences of young children living with sickle<br>cell. These child-led contributions helped to<br>humanize the condition, reduce stigma, and raise<br>awareness across wider society.<br>A key highlight this year was being selected to<br>deliver a TEDxNHS talk, giving us a national<br>platform to share the realities of living with sickle<br>cell from a parent-led perspective. This<br>opportunity amplified our message and inspired<br>wider conversations around health equity,<br>childhood chronic illness, and the power of lived<br>experience.<br>Our work has made a meaningful difference by<br>educating families, building community, and<br>giving children a platform to be heard. It has also|





contributed to broader public understanding, helping shift perceptions and promote more inclusive support in schools, healthcare, and beyond. 

## **Achievements and performance** 

|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|During this reporting period, Crescent Kids made<br>significant progress in raising awareness and<br>supporting families affected by sickle cell disease<br>through accessible education and storytelling.<br>We delivered a series of online education<br>sessions for parents, carers, and professionals,<br>equipping them with practical tools to better<br>support children living with sickle cell. These<br>sessions helped reduce isolation, improve<br>confidence, and empower families to advocate<br>more effectively in healthcare and education<br>settings.<br>We also launched our YouTube channel and<br>continued to grow our community on Instagram<br>and LinkedIn, using these platforms to share<br>engaging, child-friendly educational videos. Much<br>of our content featured the voices of our young<br>volunteer contributors, giving children a platform<br>to share their experiences and be part of the<br>conversation. This not only built their confidence<br>but also helped reduce stigma by educating<br>wider audiences.<br>A key milestone was our invitation to speak at<br>TEDxNHS, where we shared the lived<br>experience of raising a child with sickle cell and<br>the gaps that still exist in support. This national<br>platform helped us reach new audiences, spark<br>meaningful dialogue, and advocate for more<br>inclusive systems.<br>Together, these efforts have improved<br>understanding, uplifted families, and contributed<br>to a more informed, compassionate society.|
|---|---|---|



## **Reference and administrative details** 

Charity name Other name the charity uses Registered charity number Charity’s principal address 

## **Names of the charity trustees who manage the charity** 

|1<br>2|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Professor Alastair<br>Sutcliffe||||
||MaryAkinbiyi||||






**----- Start of picture text -----**<br>
3 Tamsin Hunt<br>4 Vanessa Ullam<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20<br>**----- End of picture text -----**<br>


## **Funds held as custodian trustees on behalf of others** 

Description of the assets N/A held in this capacity Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for safe custody and segregation of such assets from the charity’s own assets 

## **Declarations** 

**Signed on behalf of the charity’s trustees/directors** 



**Signature(s)** _Funmi Vanessa Ullam_ **Full name(s)** Funmi Vanessa Ullam **Position (for example** Trustee/CEO **Secretary, Chair, etc) Date** 18th of April 2025 




**----- Start of picture text -----**<br>
||||||||||
|---|---|---|---|---|---|---|---|---|
|Charity Name|No (if any)|
|Crescent Kids|1173388|
|Receipts and payments accounts|CC16a|
|For the period|01/04/2023|01/04/2024|
|To|
|from|
|ee|ee|ee||
|Section A Receipts and payments|
|Unrestricted|Restricted|Endowment|
|Total funds|Last year|
|funds|funds|funds|
|to the nearest      £|to the nearest £|to the nearest £|to the nearest £|to the nearest £|
|A1 Receipts|
|CG Benevity|24|-|-|24|-|
|Family Donation|200|-|-|200|-|
|-|-|-|-|-|
|-|-|-|-|-|
|-|-|-|-|-|
|-|-|-|-|-|
|-|-|-|-|-|
|-|-|-|-|-|
|Sub total|(Gross income for|
|AR)|[                          224 ]|-|-|224|-|
|A2 Asset and investment sales,|
|(see table).|
|-|-|-|-|
|-|-|-|-|-|
|Sub total|-|-|-|-|-|
|Total receipts|224|-|-|224|-|
|SS5|55|
|A3 Payments|
|Vodafone|150|-|-|150|-|
|Prontaprint Camden|55|-|-|55|-|
|-|-|-|-|
|-|-|-|-|
|-|-|-|-|-|
|-|-|-|-|-|
|-|-|-|-|-|
|-|-|-|-|-|
|-|-|-|-|-|
|Sub total|[                          205 ]|-|-|205|-|
|A4 Asset and investment|
|purchases, (see table)|
|-|-|-|-|
|-|-|-|-|
|Sub total|[                               - ]|-|-|-|-|
|SS|Total payments|205|5|-|-|5—|205|-|
|Net of receipts/(payments)|19|-|-                           19|-|
|A5 Transfers between funds|-|-                           -|-|-|
|A6 Cash funds last year end|-|-                           -|-|-|
|Cash funds this year end|19|-|-                           19|-|
|===|==|>= >|

**----- End of picture text -----**<br>


CCXX R1 accounts (SS) 

18/04/2025 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>**B3 Investment assets**|Signature<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Agreement Error<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name|**Endowment**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**|
|---|---|---|---|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**When due**<br>**(optional)**<br>Date of<br>approval|



CCXX R2 accounts (SS) 

18/04/2025 

2 

